期刊文献+

大蒜辣素对多药耐药HepG2细胞中MDR1基因表达影响 被引量:4

暂未订购
导出
摘要 目的多药耐药(MDR)是肿瘤化疗的主要障碍,该研究旨在体外建立MDR人肝癌HepG2细胞株(HepG2/mdr),并探讨大蒜辣素(Allicin)对MDR1表达的影响。方法采用高效液相色谱法(HPLC)提纯Allicin,采用间歇逐步增加阿霉素(adramycin,ADM)剂量法建立人肝癌MDR细胞株HepG2/mdr,运用细胞计数试剂盒(Cell counting kit-8,CCK-8)检测耐药细胞株耐药性,运用倒置显微镜观察不同浓度Allicin孵育下HepG2/mdr细胞形态学变化,运用逆转录聚合酶链反应(RT-PCR)及免疫印迹(Western blot)测定不同浓度Allicin作用下,HepG2/mdr细胞MDR1mRNA与蛋白表达情况。结果 Allicin经HPLC法提纯后其纯度达到99%。在2000nmol/L ADM作用下,HepG2/mdr细胞生长良好,而HepG2细胞生长停滞与死亡,且Allicin能阻止HepG2/mdr细胞生长,促进其死亡,随着Allicin浓度增加越加明显。Allicin能降低MDR1 mRNA和蛋白表达,呈现剂量依赖性。结论成功建立人肝癌MDR细胞株HepG2/mdr,Allicin能通过抑制MRD1基因的表达,恢复肿瘤细胞对化疗药物的敏感性。
出处 《时珍国医国药》 CAS CSCD 北大核心 2012年第1期233-235,共3页 Lishizhen Medicine and Materia Medica Research
  • 相关文献

参考文献17

  • 1Low C F, Chong P P, Yong P V, et al. Inhibition of hyphae formation and SIR2 expression in Candida albicans treated with fresh Allium sativum (garlic) extract[J]. J Appl Mierobiol,2008,105 (6) :2169.
  • 2Cutler RR, Odent M, Hajj-Abroad H, et aL In vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci [ J]. J Antimicrob Chemother,2009,63 (1):151.
  • 3Zhang Y, Yao HP, Huang FF, et al. Allicin, a major component of garlic, inhibits apoptosis in vital organs in rats with trauma/hemorrhagic shock[J]. Crit Care Med ,2008,36 ( 12 ) :3226.
  • 4Sela U, Brill A, Kalchenko V, et al. Allicin inhibits blood vessel growth and downregulates Akt phosphorylation and aetin polymerization [ J ]. Nutr Cancer,2008,60 ( 3 ) :412.
  • 5Chung LY. The antioxidant properties of garlic compounds : allyl cysteine, alliin, allicin, and allyl disulfide[J]. J Med Food,2006,9(2) :205.
  • 6Gonen A, Harats D, Rabinkov A, et al. The antiatherogenic effect of allicin : possible mode of action [ J ]. Pathobiology, 2005,72 ( 6 ) : 325.
  • 7Baguley BC. Multiple drug resistance mechanisms in cancer [ J ]. Mol Biotechno1,2010,46 ( 3 ) :308.
  • 8European Directorate for the Quality of Medicines & HealthCare, The Europe~an Pharmacopoeia 5 th Edition ( Ep5. O) [ M ] : 1651,1637.
  • 9Liu FS. Mechanisms of chemotherapeutic drug resistance in cancer therapy a quick review[J]. Taiwan J Obstet Gynecol,2009,48 (3) :239.
  • 10Millen AE, Subar AF, Graubard BI, et ah Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial [ J ]. Am J Clin Nutr,2007,86 ( 6 ) : 1754.

二级参考文献15

  • 1高世勇,王秋娟,季宇彬.龙葵碱对HepG2细胞内caspase-3及Bcl-2蛋白含量的影响[J].中国天然药物,2006,4(3):224-229. 被引量:8
  • 2Li Y, Xu YS, Sun DW, Preparation of garlic powder with high alliein content by using combined microwave - vacuum and vacuum drying as well as microencapsulation[ J]. Jour of Food Engin,2007, 83 ( 1 ) : 76.
  • 3Seong - Jun Cho, Dong - Kwon Rhee, Suhkneung Pyo. Allicin, a major component of garlic, inhibits apoptosis of macrophage in a depleted nutritional state [ J ]. Nutrition,2006, 22 ( 11 - 12 ) : 1177.
  • 4Curtis H, Noll U, Stormann J, et al, Broad - spectrum activity of the volatile phytoantieipin allicin in extracts of garlic ( Allium sativum L. ) against plant pathogenic bacteria, fungi and Oomycetes [ J ]. Physi and Mole Plant Path,2004, 65(2) : 79.
  • 5Oommen S, John A R, Srinivas G, et al, Allicin (from garlic) induces caspase -mediated apoptosis in cancer cells [ J ]. Euro Jour of Pharma, 2004, 485 ( 1 - 3 ) : 97.
  • 6Miron T, SivaRaman H, Rabinkov A, A method for continuous production of allicin using immobilized alliinase, [ J ]. Analyti Biochem,2006, 351(1): 152.
  • 7European Directorate for the Quality of Medicines & HeahhCare, The European Pharmacopoeia 5 th Edition ( Ep5. 0) [ M ]. : 1651
  • 8Choi J, Hwang YK, Sung KW, et al, Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia[J]. Blood,2007, 109 (2) :471.
  • 9Son E W, Mo S J, Rhee D K, et al, Inhibition of ICAM - 1 expression by garlic component, allicin, in gamma - irradiated human vascular endothelial cells via downregulation of the JNK signaling pathway [ J ]. Inter Immunopharm,2006, 6(12) : 1788.
  • 10European Directorate for the Quality of Medicines & HealthCare, The European Pharmacopoeia 5 th Edition (Ep5.0) [ M ]. 1637.

共引文献3

同被引文献67

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部